IL1B and myocardial infarction: A study reported that miR-132 can target IL1B in myocardial infarction to inhibit apoptosis of myocardial cells (Zhao et al., 2020), further demonstrating the potential of IL1B as a target for apoptosis intervention and a biomarker.